|
|
||||||||



* Skirball Institute of Biomedical Research and
Department of Medicine, New York University School of Medicine, New York, NY 10016; and
Department of Pharmaceutics, Rutgers University College of Pharmacy, Piscataway, NJ 08854
Nef is a crucial viral protein for HIV to replicate at high titers and in the development of AIDS. One Nef function is down-regulating CD4 from the cell surface, which correlates with Nef-enhanced viral pathogenicity. Nef down-regulates CD4 by linking CD4 to clathrin-coated pits. However, the mechanistic connection between the C-terminal dileucine motif of Nef and the component(s) of the clathrin-coated pits has not been pinpointed. In this report we used two AP-2 complex-specific inhibitors: a dominant negative mutant of Eps15 (Eps15DIII) that binds to the
subunit of AP-2 complex and a small interference RNA that is specific for the µ2 subunit of AP-2 complex. We show that both HIV Nef- and SIV Nef-mediated CD4 down-regulations were profoundly blocked by the synergistic effect of Eps15DIII and RNA interference of AP-2 expression. The results demonstrate that HIV/SIV Nef-mediated CD4 down-regulation is AP-2 dependent. We also show that the PMA-induced CD4 down-regulation was blocked by these two inhibitors. Therefore, PMA-induced CD4 down-regulation is also AP-2 dependent. The results demonstrate that, like the tyrosine sorting motif-dependent endocytosis (for which the transferrin receptor and the epidermal growth factor receptor are the two prototypes), dileucine sorting motif-dependent endocytosis of Nef and CD4 are also AP-2 dependent.
This article has been cited by other articles:
![]() |
N. Laguette, C. Bregnard, J. Bouchet, A. Benmerah, S. Benichou, and S. Basmaciogullari Nef-Induced CD4 Endocytosis in Human Immunodeficiency Virus Type 1 Host Cells: Role of p56lck Kinase J. Virol., July 15, 2009; 83(14): 7117 - 7128. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. L. P. daSilva, R. Sougrat, P. V. Burgos, K. Janvier, R. Mattera, and J. S. Bonifacino Human Immunodeficiency Virus Type 1 Nef Protein Targets CD4 to the Multivesicular Body Pathway J. Virol., July 1, 2009; 83(13): 6578 - 6590. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Chaudhuri, R. Mattera, O. W. Lindwasser, M. S. Robinson, and J. S. Bonifacino A Basic Patch on {alpha}-Adaptin Is Required for Binding of Human Immunodeficiency Virus Type 1 Nef and Cooperative Assembly of a CD4-Nef-AP-2 Complex J. Virol., March 15, 2009; 83(6): 2518 - 2530. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y.-J. Jin, C. Y. Cai, X. Zhang, and S. J. Burakoff Lysine 144, a Ubiquitin Attachment Site in HIV-1 Nef, Is Required for Nef-Mediated CD4 Down-Regulation J. Immunol., June 15, 2008; 180(12): 7878 - 7886. [Abstract] [Full Text] [PDF] |
||||
![]() |
O. W. Lindwasser, W. J. Smith, R. Chaudhuri, P. Yang, J. H. Hurley, and J. S. Bonifacino A Diacidic Motif in Human Immunodeficiency Virus Type 1 Nef Is a Novel Determinant of Binding to AP-2 J. Virol., February 1, 2008; 82(3): 1166 - 1174. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. Hubner, P. Chen, A. D. Portillo, Y. Liu, R. E. Gordon, and B. K. Chen Sequence of Human Immunodeficiency Virus Type 1 (HIV-1) Gag Localization and Oligomerization Monitored with Live Confocal Imaging of a Replication-Competent, Fluorescently Tagged HIV-1 J. Virol., November 15, 2007; 81(22): 12596 - 12607. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Chaudhuri, O. W. Lindwasser, W. J. Smith, J. H. Hurley, and J. S. Bonifacino Downregulation of CD4 by Human Immunodeficiency Virus Type 1 Nef Is Dependent on Clathrin and Involves Direct Interaction of Nef with the AP2 Clathrin Adaptor J. Virol., April 15, 2007; 81(8): 3877 - 3890. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. S. Loomis, R. J. Courtney, and J. W. Wills Packaging Determinants in the UL11 Tegument Protein of Herpes Simplex Virus Type 1 J. Virol., November 1, 2006; 80(21): 10534 - 10541. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. F. Roeth and K. L. Collins Human Immunodeficiency Virus Type 1 Nef: Adapting to Intracellular Trafficking Pathways Microbiol. Mol. Biol. Rev., June 1, 2006; 70(2): 548 - 563. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |